trypanosomiasis therapy (Universidad de Buenos Aires)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nametrypanosomiasis therapy (Universidad de Buenos Aires)
Drug Alias Nametrypanosomiasis therapy (University of Illinois)WC-9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGeranylgeranyl pyrophosphate synthase inhibitorsSqualene synthase inhibitors
TargetsGeranylgeranyl pyrophosphate synthaseSqualene synthase
Therapy Area/IndicationsTrypanosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesArgentina
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Buenos Aires
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of IllinoisUniversity Of Buenos Aires
Active IndicationsN/A
Inactive IndicationsTrypanosomiasis

Other Information

ATC CodeN/A
Related LinksN/A